Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03525925 |
Title | Ibrutinib and Nivolumab in Treating Participants With Metastatic Solid Tumors |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Ohio State University Comprehensive Cancer Center |
Indications | |
Therapies | |
Age Groups: | adult | child | senior |
Covered Countries | USA |